selected scholarly activity
-
conferences
- Automated Data Extraction from Electronic Medical Records in Rheumatology: An Ontario Best Practices Research Initiative Pilot Project (OBRI). Journal of Rheumatology. 863-864. 2017
- Evaluation Of A Chronic Disease Management System For The Treatment And Management Of Diabetes In Primary Health Care Practices In Ontario. Value in Health. A144-A144. 2014
- Improving cardiovascular health at the population level: a 39 community cluster-randomized trial of the Cardiovascular Health Awareness Program (C-CHAP). Stroke. E474-E474. 2010
- IMPROVING CARDIOVASCULAR HEALTH AT THE POPULATION LEVEL: A 39 COMMUNITY CLUSTER-RANDOMISED TRIAL OF THE CARDIOVASCULAR HEALTH AWARENESS PROGRAM (CHAP): PS.3.03. Journal of Hypertension. e602-e602. 2010
- A randomized trial of computer and pamphlet-based versions of the Decision Board (DB). Journal of Clinical Oncology. 2007
- DECIDE - A descriptive study on the effectiveness of the animal fluency test to detect cognitive impairment and dementia in elderly with vascular risk factors.. Journal of The American Geriatrics Society. S30-S30. 2007
- Prognostic factors for first clinical fracture in patients with primary osteoporosis: Data from the Canadian database of osteoporosis and osteopenia (CANDOO).. Journal of Bone and Mineral Research. S108-S108. 2006
- Low rates of vitamin D supplementation in Canadians with low bone mass or fractures. Osteoporosis International. S229-S229. 2006
- Evaluation of easily measured risk factors in the prediction of osteoporotic fractures.. Journal of Bone and Mineral Research. S90-S90. 2004
- Impact of non-compliance and non-persistence with daily Bisphosphonates on longer-term effectiveness outcomes in patients with osteoporosis.. Journal of Bone and Mineral Research. S445-S445. 2004
- Impact of non-compliance and non-persistence with daily bisphosphonates on longer-term effectiveness outcomes in patients with osteoporosis treated in tertiary specialist care. Annals of the Rheumatic Diseases. 96-97. 2004
- Inability to rise from a chair predicts hip fracture in clinical practice. Journal of Aging and Physical Activity. 269-270. 2004
- Longer term effectiveness outcomes of noncompliance and nonpersistence with daily regimen bisphosphonate therapy in patients with osteoporosis treated in tertiary specialist care. Osteoporosis International. S107-S107. 2004
- Utilization of venous thromboprophylaxis in acutely ill medical patients in Canada: Results from the Canadian Registry (CURVE).. Blood. 498A-498A. 2003
- Men have a higher rate of prevalent fractures compared to women when started on bisphosphonate therapy: The Canadian Database of Osteoporosis and Osteopenia.. Arthritis and Rheumatism. S299-S299. 2003
- Men present with a higher rate of prevalent fractures than women when started on bisphosphonate therapy in Canadian specialty osteoporosis practices.. Journal of Bone and Mineral Research. S364-S364. 2003
- Predictors of change of disease modifying antirheumatic drugs in patients with rheumatoid arthritis from the CORRONA database.. Arthritis and Rheumatism. S338-S338. 2003
- Predictors of early failure of bisphosphonate therapy: The Canadian database of osteoporosis and osteopenia (CANDOO).. Arthritis and Rheumatism. S449-S449. 2003
- Risk factors associated with quality of life (QOL) in postmenopausal women with prevalent vertebral fractures: the Canadian database of osteoporosis and osteopenia (CANDOO).. Arthritis and Rheumatism. S83-S83. 2003
- Risk factors related with quality of life (QOL) in postmenopausal women with prevalent vertebral fractures: The Canadian Database of Osteoporosis and Osteopenia (CANDOO).. Journal of Bone and Mineral Research. S247-S247. 2003
- A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 17-22. 2003
- Risk factors that predict new fractures in postmenopausal women: The Canadian database for osteoporosis and osteopenia (CANDOO). Osteoporosis International. S7-S7. 2003
- The effectiveness of etidronate and alendronate in the treatment of osteoporosis in women with a history of breast cancer: The Canadian database for osteoporosis and osteopenia (CANDOO). Osteoporosis International. S41-S41. 2003
- Adherence profile of etidronate (ETD), alendronate (ALD) and hormone replacement therapy (HRT) in patients registered in the Canadian Database of Osteoporosis and Osteopenia (CANDOO).. Journal of Bone and Mineral Research. S270-S270. 2002
- CANDOO: A longitudinal Canadian multi-center tertiary-care network for observational research in osteoporosis and osteopenia using standardized clinical practice data: 11 years of follow-up. Journal of Bone and Mineral Research. S358-S358. 2002
- High dose intravenous proton pump inhibitors (IV PPI) decrease hospital mortality in selected patients with upper gastrointestinal bleeding. American Journal of Gastroenterology. S230-S230. 2002
- Impact of drug plan coverage on NSAID and coxib prescribing by primary care physicians.. Arthritis and Rheumatism. S156-S157. 2002
- The influence of bone mineral density (BMD) testing on the treatment of osteoporosis (OP) in two Canadian non-academic community centres.. Journal of Bone and Mineral Research. S414-S414. 2002
- High dose intravenous proton pump inhibition improved outcomes in unselected patients who undergo endoscopy for acute non-variceal upper GI bleeding. Gastroenterology. A477-A477. 2002
- Predictors of mortality in patients with nonvariceal upper GI bleeding following endoscopy in the era of intravenous proton pump inhibition (IVPPI) and newer endoscopic therapies. Gastrointestinal Endoscopy. AB177-AB177. 2002
- CANDOO: A longitudinal canadian multicenter tertiary-care network for observational research in osteoporosis (OP) and osteopenia using standardized clinical practice data: 11 years of follow-up. Osteoporosis International. S28-S28. 2002
- Iliocostal distance (ILCD) is associated with prevalent vertebral (VERT) and non-vertebral (NV) fractures in patients registered in the Canadian database of osteoporosis and osteopenia (CANDOO). Osteoporosis International. S79-S79. 2002
- The prevalence of secondary causes of osteoporosis. Osteoporosis International. S136-S137. 2002
- CANDOO: A longitudinal Canadian multi-center tertiary-care network for observational research in osteoporosis and osteopenia using standardized clinical practice data: 11 years of follow-up.. Arthritis and Rheumatism. S257-S257. 2001
- Characteristics of patients with OA receiving NSAID prescriptions from their primary care physicians - Results from the CANOAR study.. Arthritis and Rheumatism. S134-S134. 2001
- Measures of appropriateness of use of NSAIDs and coxibs in patients with OA by primary care physicians - Results from the CANOAR study.. Arthritis and Rheumatism. S134-S134. 2001
- New England Registry for Paget's disease of bone.. Journal of Bone and Mineral Research. S302-S302. 2001
- The impact of treatment interventions on health related quality of life (HRQL) in post-menopausal women registered in the Canadian Database of Osteoporosis and Osteopenia (CANDOO) patients.. Journal of Bone and Mineral Research. S541-S541. 2001
- The impact of treatment interventions on health related qualtiy of life (HRQL) in post-menopausal women registered in the Canadian database of osteoporosis and osteopenia (CANDOO) patients.. Arthritis and Rheumatism. S257-S257. 2001
- The effects of treatment interventions on health related quality of life (HRQL) in post-menopausal women registered in the Canadian Database of Osteoporosis and Osteopenia (CANDOO) patients. Bone. S241-S241. 2001
- Effectiveness of etidronate and alendronate in the treatment of osteoporosis in males: A prospective observational study.. Arthritis and Rheumatism. S205-S205. 2000
- Effectiveness of etidronate and alendronate in the treatment of osteoporosis in males: a prospective observational study.. Journal of Bone and Mineral Research. S308-S308. 2000
- Non-vertebral fractures and quality of life.. Arthritis and Rheumatism. S397-S397. 2000
- Non-vertebral fractures and quality of life.. Journal of Bone and Mineral Research. S562-S562. 2000
- Patient adherence to bisphosphonate therapy.. Journal of Bone and Mineral Research. S433-S433. 2000
- Patient adherence to bisphosphonate therapy.. Arthritis and Rheumatism. S201-S201. 2000
- Vertebral fractures and quality of life.. Arthritis and Rheumatism. S199-S199. 2000
- Vertebral fractures and quality of life.. Journal of Bone and Mineral Research. S562-S562. 2000
- Effectiveness of etidronate and alendronate in the treatment of osteoporosis in males: A prospective observational study. Osteoporosis International. S199-S199. 2000
- Patient compliance with bisphosphonate therapy. Osteoporosis International. S200-S200. 2000
- Vertebral fractures and quality of life. Osteoporosis International. S200-S200. 2000
- Impact of first-time bone mineral density testing on osteoporosis-related treatment patterns in 2 non-academic settings.. Journal of Bone and Mineral Research. S529-S529. 1999
- Addition of bisphosphonate therapy with etidronate or alendronate to stable estrogen replacement therapy in postmenopausal women increases lumbar spine and femoral trochanter bone mineral density.. Arthritis and Rheumatism. S44-S44. 1998
- Intermittent cyclical therapy with etidronate prevents corticosteroid-induced bone loss: Three years of follow-up.. Arthritis and Rheumatism. S302-S302. 1998
- The effect of etidronate on lumbar spine bone mineral density in men.. Arthritis and Rheumatism. S44-S44. 1998
- Comparison of BMD measurements at 6 and 12 months in assessing response to etidronate in osteoporosis. Journal of Bone and Mineral Research. S486-S486. 1997
- Fluoride therapy in the prevention of rheumatoid arthritis induced bone loss.. Journal of Bone and Mineral Research. S641-S641. 1997
- Intermittent cyclic therapy with etidronate prevents corticosteroid-induced bone loss: Three years of follow-up. Journal of Bone and Mineral Research. S630-S630. 1997
- Intermittent cyclical etidronate therapy for the prevention of rheumatoid arthritis induced bone loss following 18 months of fluoride therapy or placebo.. Journal of Bone and Mineral Research. S642-S642. 1997
- Diradylglycerol formation is altered by n-3 highly unsaturated fatty acids, with differences between eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids.. Advances in Experimental Medicine and Biology. 937-945. 1997
- A randomized, double-blind, placebo-controlled trial of the effects of fluoride on lumbar spine bone mineral density in patients with rheumatoid arthritis.. Arthritis and Rheumatism. 661-661. 1996
- Comparison of etidronate and estrogen: Effects on lumbar spinal bone mineral density change and vertebral fracture rate.. Journal of Bone and Mineral Research. M652-M652. 1996
- Formation of sn-1,2-diradylglycerol following eicosapentaenoic and docosahexaenoic ethyl ester supplementation in vivo.. The FASEB Journal. 4171-4171. 1996
- INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 2 YEARS OF FOLLOW-UP. Journal of Bone and Mineral Research. S253-S253. 1995
- WILLINGNESS TO INITIATE HORMONE REPLACEMENT THERAPY FOR PREVENTION OR TREATMENT OF OSTEOPOROSIS - IDENTIFICATION OF PATIENT SUBSETS. Journal of Bone and Mineral Research. S252-S252. 1995
- INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 2 YEARS OF FOLLOW-UP. Arthritis and Rheumatism. R34-R34. 1995
- 2ND MESSENGER DIRADYLGLYCEROL FORMATION IN MURINE PERITONEAL-MACROPHAGES IS ALTERED FOLLOWING IN-VIVO N-3 FATTY-ACID SUPPLEMENTATION - QUANTITATIVE AND MOLECULAR-SPECIES DETERMINATION. The FASEB Journal. A441-A441. 1995
- FISH-OIL N-3 FATTY-ACIDS ALTER DIACYLGLYCEROL (DAG) FORMATION IN INFLAMMATORY MACROPHAGES - A POTENTIAL EICOSANOID-INDEPENDENT MECHANISM OF THEIR ACTION. Arthritis and Rheumatism. S108-S108. 1993
- INTERMITTENT CYCLIC ETIDRONATE THERAPY (ICT) PREVENTS CORTICOSTEROID-INDUCED BONE LOSS. Arthritis and Rheumatism. S51-S51. 1993
- PULSE GLUCOCORTICOSTEROID (GCS) THERAPY IN RA PATIENTS INHIBITS WHOLE-BLOOD LEUKOTRIENE B4(LTB4) BIOSYNTHESIS EX-VIVO. Arthritis and Rheumatism. S269-S269. 1993
- VITAMIN-D AND CALCIUM IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS - FOLLOW-UP OVER 3 YEARS. Arthritis and Rheumatism. S51-S51. 1993
- INTERMITTENT CYCLIC ETIDRONATE THERAPY (ICT) PREVENTS CORTICOSTEROID-INDUCED BONE LOSS. Journal of Bone and Mineral Research. S325-S325. 1993
- FISH OIL N-3 FATTY-ACIDS ALTER DIACYLGLYCEROL (DAG) FORMATION IN INFLAMMATORY MACROPHAGES - A POTENTIAL EICOSANOID-INDEPENDENT MECHANISM OF THEIR ACTION. Arthritis and Rheumatism. R31-R31. 1993
- PULSE GLUCOCORTICOSTEROID (GCS) THERAPY IN RA PATIENTS INHIBITS WHOLE-BLOOD LEUKOTRIENE-B4 (LTB4) BIOSYNTHESIS EXVIVO. Arthritis and Rheumatism. R35-R35. 1993
- NASAL SALMON-CALCITONIN IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS. Arthritis and Rheumatism. S120-S120. 1992
- NASAL SALMON-CALCITONIN IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS. Journal of Bone and Mineral Research. S193-S193. 1992
- EFFECTS OF HIGH-DOSE GLUCOCORTICOSTEROID ADMINISTRATION ON EICOSANOID BIOSYNTHESIS BY HUMAN ALVEOLAR MACROPHAGES. Clinical Research. A569-A569. 1988
- EICOSANOID (E) BIOSYNTHESIS AND LEUKOTRIENE (LT)-B4 RELEASE DURING STEROID-ADMINISTRATION IN MAN. Clinical Research. A381-A381. 1987
- ENDOGENOUS LEUKOTRIENE B-4 (LTB4) IN RHEUMATOID-ARTHRITIS (RA). Clinical Research. A567-A567. 1987
-
journal articles
- Using Digital Health Technology to Prevent and Treat Diabetes. Diabetes Technology and Therapeutics. 18:S56-S68. 2016
- The Relationship Between Dermatologist- and Patient-Reported Acne Severity Measures and Treatment Recommendations. Journal of Cutaneous Medicine and Surgery. 19:464-469. 2015
- Development and Validation of the McMaster Prescribing Competency Assessment for Medical Trainees (MacPCA).. Journal of Population Therapeutics and Clinical Pharmacology. 22:e173-e178. 2015
- Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational study.. Ontario Health Technology Assessment Series. 14:1-37. 2014
- Effect of provider and patient reminders, deployment of nurse practitioners, and financial incentives on cervical and breast cancer screening rates.. Canadian Family Physician. 59:e282-e289. 2013
- Community Mobilization, Participation, and Blood Pressure Status in a Cardiovascular Health Awareness Program in Ontario. American Journal of Health Promotion. 27:252-261. 2013
- Community mobilization, participation, and blood pressure status in a Cardiovascular Health Awareness Program in Ontario.. American Journal of Health Promotion. 27:252-261. 2013
- Impact of a computerized system for evidence-based diabetes care on completeness of records: a before–after study. BMC Medical Informatics and Decision Making. 12:63. 2012
- Computerized clinical decision support systems for chronic disease management: A decision-maker-researcher partnership systematic review. Implementation Science. 6:92. 2011
- Computerized clinical decision support systems for primary preventive care: A decision-maker-researcher partnership systematic review of effects on process of care and patient outcomes. Implementation Science. 6:87. 2011
- Development and Validation of a Scale for Acne Scar Severity (SCAR-S) of the Face and Trunk. Journal of Cutaneous Medicine and Surgery. 14:156-160. 2010
- Detection of Cognitive Impairment and Dementia Using the Animal Fluency Test: The DECIDE Study. Canadian Journal of Neurological Sciences. 36:599-604. 2009
- Effect of Quality of Life Impact and Clinical Severity on Adherence to Topical Acne Treatment. Journal of Cutaneous Medicine and Surgery. 13:204-208. 2009
- Women's views on reminder letters for screening mammography: Mixed methods study of women from 23 family health networks.. Canadian Family Physician. 55:622-3.e1-4. 2009
- Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study – observational. Current Medical Research and Opinion. 25:47-55. 2009
- Heart and Stroke Foundation of Ontario (HSFO) high blood pressure strategy's hypertension management initiative study protocol. BMC Health Services Research. 8:251. 2008
- Divergence of Demographic Factors Associated with Clinical Severity Compared with Quality of Life Impact in Acne. Journal of Cutaneous Medicine and Surgery. 12:235-242. 2008
- Enhancing hypertension awareness and management in the elderly: Lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP). Canadian Journal of Cardiology. 24:561-567. 2008
- Cardiovascular Health Awareness Program (CHAP): A community cluster-randomised trial among elderly Canadians. Preventive Medicine. 46:537-544. 2008
- Prevalence and severity of facial and truncal acne in a referral cohort. Journal of Drugs in Dermatology. 7:553-556. 2008
- Prevalence and severity of facial and truncal acne in a referral cohort.. Journal of Drugs in Dermatology. 7:551-556. 2008
- Patient Views on Reminder Letters for Influenza Vaccinations in an Older Primary Care Patient Population. Canadian Journal of Public Health. 99:133-136. 2008
- Practice Patterns in the Management of Chronic Obstructive Pulmonary Disease in Primary Practice: The Cage Study. Canadian Respiratory Journal. 15:13-19. 2008
- Practice and Physician Characteristics Associated with Influenza Vaccination Delivery Rates Following a Patient Reminder Letter Intervention. JOURNAL OF PREVENTION. 29:93-97. 2008
- Development and Validation of a Comprehensive Acne Severity Scale. Journal of Cutaneous Medicine and Surgery. 11:211-216. 2007
- Acceptability of Reminder Letters for Papanicolaou Tests: A Survey ofWomen from 23 Family Health Networks in Ontario. Journal of Obstetrics and Gynaecology Canada. 29:829-834. 2007
- Age and drug therapy are key prognostic factors for first clinical fracture in patients with primary osteoporosis. Osteoporosis International. 18:1091-1100. 2007
- Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial. CANADIAN MEDICAL ASSOCIATION JOURNAL. 176:1583-1587. 2007
- Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thrombosis Research. 119:145-155. 2007
- Views of family physicians in southwestern Ontario on preventive care services and performance incentives. Family Practice. 23:469-471. 2006
- Determinants of health-related quality of life in women with vertebral fractures. Osteoporosis International. 17:355-363. 2006
- Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study. Osteoporosis International. 17:217-224. 2006
- Evaluation of easily measured risk factors in the prediction of osteoporotic fractures. BMC Musculoskeletal Disorders. 6:47. 2005
- Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).. Canadian Journal of Cardiology. 21:1187-1193. 2005
- Are Oral Bisphosphonates Effective in Improving Lumbar Bone Mineral Density in Breast Cancer Survivors With Osteopenia or Osteoporosis?. Journal of Obstetrics and Gynaecology Canada. 27:759-764. 2005
- Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists. Arthritis and Rheumatism. 53:12-17. 2005
- Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two non-academic community centers. Osteoporosis International. 16:208-215. 2005
- Can current electronic systems meet drug safety and effectiveness requirements?. Proceedings - AMIA . Annual Symposium. AMIA Symposium. 2005:335-339. 2005
- Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: Results from the CANOAR study. American Journal of Managed Care. 10:742-750. 2004
- Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.. American Journal of Managed Care. 10:742-750. 2004
- Are there differences between men and women prescribed bisphosphonate therapy in canadian subspecialty osteoporosis practices?. Journal of Rheumatology. 31:1993-1995. 2004
- What Predicts Early Fracture or Bone Loss on Bisphosphonate Therapy?. Journal of Clinical Densitometry. 6:315-322. 2003
- CANDOO and CANOAR, CORRONA and more: advancing therapeutics through layered-in clinical data collection and feedback at the point of care.. Journal of Rheumatology. 30:2308-2311. 2003
- Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. Osteoporosis International. 14:808-813. 2003
- Analysis of Environmental Factors in Familial Versus Sporadic Paget's Disease of Bone—The New England Registry for Paget's Disease of Bone. Journal of Bone and Mineral Research. 18:1519-1524. 2003
- Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates. BMC Musculoskeletal Disorders. 3:6. 2002
- The association between iliocostal distance and the number of vertebral and non-vertebral fractures in women and men registered in the Canadian Database For Osteoporosis and Osteopenia (CANDOO). BMC Musculoskeletal Disorders. 3:22. 2002
- The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. BMC Musculoskeletal Disorders. 3:11. 2002
- Bisphosphonate addition to stable hormone replacement therapy increases bone mineral density in postmenopausal women.. Journal of Rheumatology. 29:1110-1111. 2002
- Predicting Subsequent Bone Density Response to Intermittent Cyclical Therapy with Etidronate from Initial Density Response in Patients with Osteoporosis. Osteoporosis International. 11:607-614. 2000
- 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.. Journal of Rheumatology. 26:1545-1549. 1999
- Cost effectiveness of multi-therapy treatment strategies in the prevention of vertebral fractures in postmenopausal women with osteoporosis. Climacteric. 2:237-237. 1999
- Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis. PharmacoEconomics (Auckland). 14:559-573. 1998
- Fluoride therapy in prevention of rheumatoid arthritis induced bone loss.. Journal of Rheumatology. 24:2308-2313. 1997
- Information technology and the future of medical education.. Clinical and Investigative Medicine. 20:419-421. 1997
- Salmon calcitonin nasal spray in the prevention of corticosteroid- induced osteoporosis. Rheumatology. 36:255-259. 1997
- The formation of diradylglycerol molecular species in murine peritoneal macrophages varies dose-dependently with dietary purified eicosapentaenoic and docosahexaenoic ethyl esters.. Journal of Nutrition. 126:2738-2745. 1996
- Acyl Chain Dependence of Diacylglycerol Activation of Protein Kinase C Activityin Vitro. Biochemical and Biophysical Research Communications. 225:469-473. 1996
- n‐3 Polyunsaturated fatty acid‐induced changes in the molecular species composition of diradylglycerol in murine peritoneal macrophages remain stable during incubationex vivo. Lipids. 31:771-776. 1996
- Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.. Journal of Rheumatology. 23:995-1000. 1996
- Evidence based health informatics: an overview of the Health Information Research Unit at McMaster University.. Leadership in Health Services. 5:41-44. 1996
- Intermittent Cyclic Therapy with Etidronate Prevents Corticosteroid-induced Bone Loss: Two Years of Follow-up. Scandinavian Journal of Rheumatology. 25:91-93. 1996
- Formation of second messenger diradylglycerol in murine peritoneal macrophages is altered after in vivo (n-3) polyunsaturated fatty acid supplementation.. Journal of Nutrition. 125:3030-3040. 1995
- Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.. Journal of Rheumatology. 21:1922-1926. 1994
- Quantification of contributions of phospholipid precursors to diradylglycerols in stimulated mononuclear phagocytes. Biochemical Journal. 284:367-375. 1992
- Inhibition of eicosanoid biosynthesis by glucocorticoids in humans.. Proceedings of the National Academy of Sciences of the United States of America. 87:6974-6978. 1990
- IFN-gamma potentiates the accumulation of diacylglycerol in murine macrophages.. Journal of Immunology. 145:684-689. 1990
- PULSE STEROID-THERAPY, RHEUMATOID-ARTHRITIS AND THE JOURNAL-OF-RHEUMATOLOGY - REPLY. Journal of Rheumatology. 15:1873-1873. 1988
- Pulse steroid therapy and the search for improved drug therapy of rheumatoid arthritis.. Journal of Rheumatology. 15:200-201. 1988
- Efficient Pharmacokinetic Modeling of Complex Clinical Dosing Regimens: The Universal Elementary Dosing Regimen and Computer Algorithm EDFAST. Journal of Pharmaceutical Sciences. 76:93-100. 1987
- A shorter plasma half life does not predict less drug accumulation.. Journal of Rheumatology. 13:1185-1186. 1986
- Mathematical modelling of pathogenesis and treatment: new insights into old questions.. Journal of Rheumatology. 12:824-828. 1985
- Lidocaine Therapy with an Exponentially Declining Infusion. ACP journal club. 101:632-632. 1984
- Sympathetic synovial effusion associated with septic prepatellar bursitis: synovial fluid analysis with therapeutic implications.. Journal of Rheumatology. 11:555-556. 1984